Company / Working Capital per Share
Roivant Sciences Working Capital per Share History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$8.01
FY2024
5-year range
$2.01 / $8.01
FY2021-FY2024
Trend
+299.2%
vs FY2023
Sector context
#63 of 210
Health Care
What the data says
Working Capital per Share changed +299% YoY in FY2024, a notable deviation from the 3-year average annual change of +89%.
Based on SEC 10-K filings.
8.01 in FY2024 with a 3-year CAGR of +39.7%.
Improved from $3.01 to $8.01 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +39.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#63 of 210 in Health CareTop 30% of 210This company $8.01 Sector average $118.60
▼
-93.2% below sector average
Key checks
Key Insights
- In FY2024, working capital per share increased 299.2% year-over-year.
- Ranks #63 out of 210 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $8.01 | +299.2% |
| FY2023 | $2.01 | -33.3% |
| FY2022 | $3.01 | +2.5% |
| FY2021 | $2.94 | - |
| FY2020 | - | - |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026